Phase 2 Study to Determine if RTB101 Reduces the Severity of COVID-19 in Older Adults Residing in Nursing Homes

NCT04409327 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

36

Enrollment

INDUSTRY

Sponsor class

Stopped Insufficient accrual rate

Conditions

COVID19

Interventions

DRUG: RTB101
DRUG: Placebo

Sponsor

Restorbio Inc.